title: [Anti-neuronal antibodies: a rapidly developing field].
abstract: Anti-neuronal antibodies are implicated in various neurological syndromes that are sometimes associated with tumors. Depending on the antigenic target (nuclear, cytoplasmic or extracellular cell-surface or synaptic) the clinical presentation is different. In neurological syndromes associated with antibodies specific for intracellular antigens, the T-cell mediated immunological response predominates as pathogenic effector and the response to treatment is typically poor. In contrast, in syndromes related to antibodies against extracellular targets, the role of the antibodies is pathogenic and the neurological syndrome often responds better to immunomodulatory treatment, associated or not with an anti-tumoral treatment. We review the spectrum of anti-neuronal antibodies and their corresponding clinical and therapeutic characteristics.
authors.affiliation: Unité de neuro-immunologie et sclérose en Plaques, Service de neurosciences cliniques, CHUV, Lassanne. anastasia.zek@gmail.com
authors.forename: A
authors.initials: A
authors.lastname: Zekeridou
authors.forename: A O
authors.initials: AO
authors.lastname: Rossetti
authors.forename: A F
authors.initials: AF
authors.lastname: Hottinger
authors.forename: R A
authors.initials: RA
authors.lastname: Du Pasquier
mesh_terms: D034961:Antigens, Nuclear / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology*; D003593:Cytoplasm / Q000276:immunology; D006801:Humans; D009474:Neurons / Q000276:immunology*
chemical_list: D034961:Antigens, Nuclear; D001323:Autoantibodies